한글목차

단일광자방출 컴퓨터단층촬영(SPECT)의 동향과 예측

세계의 단일 광자 방사 컴퓨터단층촬영(SPECT) 시장은 2024-2030년의 CAGR이 10.0%로, 2030년까지 추정 105억 달러에 달할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 헬스케어 산업의 급성장, 악성 종양이나 심혈관을 포함한 만성질환의 유병률 상승, 듀얼 모달리티 및 장기 특이적 시스템에 대한 선호도의 증가입니다. 세계의 단일광자방출 컴퓨터단층촬영(SPECT) 시장의 미래는 병원, 영상 진단 센터, 외래 수술 센터 시장에서의 비즈니스 기회로 유망시되고 있습니다.

단일광자방출 컴퓨터단층촬영(SPECT) 시장 인사이트

• Lucintel의 예측에서는 단체 SPECT가 암 및 심장혈관 부문에서의 이용이 많으므로 예측 기간 중 높은 성장이 전망됩니다.
• 이 시장내에서는 병원에 대한 입원 환자 수의 증가와 이 시설에서의 진단을 위한 SPECT 장비의 채택 증가에 의해 병원이 최대 부문으로 유지됩니다.
• 북미는 노년 인구의 존재와 심장병 및 암환자의 증가에 의해 예측 기간 중 가장 높은 성장이 전망됩니다.

본 리포트는 아래 11개의 주요 질문에 답변하고 있습니다. :

• Q.1.시장 부문 중 가장 유망하고 고성장인 기회는 무엇인가?
• Q.2.어느 부문이 보다 빠른 페이스로 성장하는가, 또 이유는?
• Q.3.향후 성장이 가속할 것으로 생각되는 지역과 이유는?
• Q.4.시장 역학에 영향을 미치는 주요 요인은 무엇인가? 시장에서 주요 과제와 비즈니스 리스크는?
• Q.5.이 시장에서 비즈니스 리스크와 경쟁의 위협은?
• Q.6.이 시장에서 새로운 동향과 이유는?
• Q.7.시장에서 고객의 수요 변화에는 어떤 것이 있는가?
• Q.8.이 시장에서 새로운 개발과 개발을 선도하고 있는 기업은?
• Q.9.이 시장의 주요 기업은? 주요 기업은 사업 성장을 위해 어떤 전략적 구상을 진행시키고 있는가?
• Q.10.이 시장에서 경쟁 제품에는 어떤 것이 있으며, 재료 및 제품의 대체에 의한 시장 점유율 저하의 위협은 어느 정도 있는가?
• Q.11.과거 5년간 어떤 M&A가 시행되고, 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 단일광자방출 컴퓨터단층촬영(SPECT) 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 2018-2030년의 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 단일광자방출 컴퓨터단층촬영(SPECT) 시장 동향(2018-2023년)과 예측(2024-2030년)
• 제품별 세계의 단일광자방출 컴퓨터단층촬영(SPECT) 시장
  • 스탠드얼론 SPECT
  • 하이브리드 SPECT
• 애플리케이션별 세계의 단일광자방출 컴퓨터단층촬영(SPECT) 시장
  • 심장병학
  • 종양학
  • 일반 영상 처리
  • 신경 내과
  • 기타
• 최종 용도별 세계의 단일광자방출 컴퓨터단층촬영(SPECT) 시장
  • 병원
  • 영상 진단 센터
  • 외래 수술 센터
  • 기타

제4장 2018-2030년의 지역별 시장 동향과 예측 분석

• 지역별 세계의 단일광자방출 컴퓨터단층촬영(SPECT) 시장
• 북미의 단일광자방출 컴퓨터단층촬영(SPECT) 시장
• 유럽의 단일광자방출 컴퓨터단층촬영(SPECT) 시장
• 아시아태평양 단일광자방출 컴퓨터단층촬영(SPECT) 시장
• 기타 지역의 단일광자방출 컴퓨터단층촬영 법(SPECT) 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 제품별 세계의 단일광자방출 컴퓨터단층촬영(SPECT) 시장의 성장 기회
  • 애플리케이션별 세계의 단일광자방출 컴퓨터단층촬영(SPECT) 시장의 성장 기회
  • 최종 용도별 세계의 단일광자방출 컴퓨터단층촬영(SPECT) 시장의 성장 기회
  • 지역별 세계의 단일광자방출 컴퓨터단층촬영(SPECT) 시장의 성장 기회
• 세계의 단일광자방출 컴퓨터단층촬영(SPECT) 시장의 새로운 동향
• 전략적 분석
  • 신제품의 개발
  • 세계의 단일광자방출 컴퓨터단층촬영(SPECT) 시장의 능력 확대
  • 세계의 단일광자방출 컴퓨터단층촬영(SPECT) 시장에서의 합병, 인수, 합병사업
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• Siemens Healthineers
• Bruker
• Toshiba Medical
• Digirad
• Esaote
• Invicro
• GE Healthcare

영문목차

Single-Photon Emission Computed Tomography (SPECT) Trends and Forecast

The future of the global single-photon emission computed tomography (SPECT) market looks promising with opportunities in the hospital, diagnostic imaging center, and ambulatory surgical center markets. The global single-photon emission computed tomography (SPECT) market is expected to reach an estimated $10.5 billion by 2030 with a CAGR of 10.0% from 2024 to 2030. The major drivers for this market are rapid growth in healthcare industry, rising prevalence of chronic diseases, including malignancies and cardiovascular, and increasing preference for dual-modality and organ-specific systems.

A more than 150-page report is developed to help in your business decisions.

Single-Photon Emission Computed Tomography (SPECT) by Segment

The study includes a forecast for the global single-photon emission computed tomography (SPECT) by product, application, end use, and region.

Single-Photon Emission Computed Tomography (SPECT) Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Standalone SPECT
• Hybrid SPECT

Single-Photon Emission Computed Tomography (SPECT) Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Cardiology
• Oncology
• General Imaging
• Neurology
• Others

Single-Photon Emission Computed Tomography (SPECT) Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Diagnostic Imaging Centers
• Ambulatory Surgical Centers
• Others

Single-Photon Emission Computed Tomography (SPECT) Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Single-Photon Emission Computed Tomography (SPECT) Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies single-photon emission computed tomography (SPECT) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the single-photon emission computed tomography (SPECT) companies profiled in this report include-

• Siemens Healthineers
• Bruker
• Toshiba Medical
• Digirad
• Esaote
• Invicro
• GE Healthcare

Single-Photon Emission Computed Tomography (SPECT) Market Insights

• Lucintel forecasts that standalone SPECT is expected to witness higher growth over the forecast period due to its significant use in the cancer and cardiovascular divisions.

• Within this market, hospital will remain the largest segment due to growing numbers of patients being admitted to hospitals and rising adoption of SPECT equipment for diagnosis in this facility.

• North America is expected to witness highest growth over the forecast period due to existence of geriatric population and increasing number of patients with heart and cancer disease in the region.

Features of the Global Single-Photon Emission Computed Tomography (SPECT) Market

• Market Size Estimates: Single-photon emission computed tomography (SPECT) market size estimation in terms of value ($B).

• Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

• Segmentation Analysis: Single-photon emission computed tomography (SPECT) market size by various segments, such as by application, end use, and region. in terms of value ($B).

• Regional Analysis: Single-photon emission computed tomography (SPECT) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

• Growth Opportunities: Analysis of growth opportunities in different applications, end uses, and region.s for the single-photon emission computed tomography (SPECT) market.

• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the single-photon emission computed tomography (SPECT) market.

• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the single-photon emission computed tomography (SPECT) market size?

Answer: The global single-photon emission computed tomography (SPECT) market is expected to reach an estimated $10.5 billion by 2030.

Q.2. What is the growth forecast for single-photon emission computed tomography (SPECT) market?

Answer: The global single-photon emission computed tomography (SPECT) market is expected to grow with a CAGR of 10.0% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the single-photon emission computed tomography (SPECT) market?

Answer: The major drivers for this market are rapid growth in healthcare industry, rising prevalence of chronic diseases, including malignancies and cardiovascular, and increasing preference for dual-modality and organ-specific systems.

Q.4. What are the major segments for single-photon emission computed tomography (SPECT) market?

Answer: The future of the single-photon emission computed tomography (SPECT) market looks promising with opportunities in the hospital, diagnostic imaging center, and ambulatory surgical center markets.

Q.5. Who are the key single-photon emission computed tomography (SPECT) market companies?

Answer: Some of the key single-photon emission computed tomography (SPECT) companies are as follows:

• Siemens Healthineers
• Bruker
• Toshiba Medical
• Digirad
• Esaote
• Invicro
• GE Healthcare

Q.6. Which single-photon emission computed tomography (SPECT) market segment will be the largest in future?

Answer: Lucintel forecasts that standalone SPECT is expected to witness higher growth over the forecast period due to its significant use in the cancer and cardiovascular divisions.

Q.7. In single-photon emission computed tomography (SPECT) market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to existence of geriatric population and increasing number of patients with heart and cancer disease in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the single-photon emission computed tomography (SPECT) market by product (standalone SPECT and hybrid SPECT), application (cardiology, oncology, general imaging, neurology, and others), end use (hospitals, diagnostic imaging centers, ambulatory surgical centers, and others)and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Single-Photon Emission Computed Tomography (SPECT) Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Single-Photon Emission Computed Tomography (SPECT) Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Single-Photon Emission Computed Tomography (SPECT) Market by Product
  • 3.3.1: Standalone SPECT
  • 3.3.2: Hybrid SPECT
• 3.4: Global Single-Photon Emission Computed Tomography (SPECT) Market by Application
  • 3.4.1: Cardiology
  • 3.4.2: Oncology
  • 3.4.3: General Imaging
  • 3.4.4: Neurology
  • 3.4.5: Others
• 3.5: Global Single-Photon Emission Computed Tomography (SPECT) Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Diagnostic Imaging Centers
  • 3.5.3: Ambulatory Surgical Centers
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Single-Photon Emission Computed Tomography (SPECT) Market by Region
• 4.2: North American Single-Photon Emission Computed Tomography (SPECT) Market
  • 4.2.2: North American Single-Photon Emission Computed Tomography (SPECT) Market by End Use: Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others
• 4.3: European Single-Photon Emission Computed Tomography (SPECT) Market
  • 4.3.1: European Single-Photon Emission Computed Tomography (SPECT) Market by Product: Standalone SPECT and Hybrid SPECT
  • 4.3.2: European Single-Photon Emission Computed Tomography (SPECT) Market by End Use: Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others
• 4.4: APAC Single-Photon Emission Computed Tomography (SPECT) Market
  • 4.4.1: APAC Single-Photon Emission Computed Tomography (SPECT) Market by Product: Standalone SPECT and Hybrid SPECT
  • 4.4.2: APAC Single-Photon Emission Computed Tomography (SPECT) Market by End Use: Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others
• 4.5: ROW Single-Photon Emission Computed Tomography (SPECT) Market
  • 4.5.1: ROW Single-Photon Emission Computed Tomography (SPECT) Market by Product: Standalone SPECT and Hybrid SPECT
  • 4.5.2: ROW Single-Photon Emission Computed Tomography (SPECT) Market by End Use: Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Single-Photon Emission Computed Tomography (SPECT) Market by Product
  • 6.1.2: Growth Opportunities for the Global Single-Photon Emission Computed Tomography (SPECT) Market by Application
  • 6.1.3: Growth Opportunities for the Global Single-Photon Emission Computed Tomography (SPECT) Market by End Use
  • 6.1.4: Growth Opportunities for the Global Single-Photon Emission Computed Tomography (SPECT) Market by Region
• 6.2: Emerging Trends in the Global Single-Photon Emission Computed Tomography (SPECT) Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Single-Photon Emission Computed Tomography (SPECT) Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Single-Photon Emission Computed Tomography (SPECT) Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Siemens Healthineers
• 7.2: Bruker
• 7.3: Toshiba Medical
• 7.4: Digirad
• 7.5: Esaote
• 7.6: Invicro
• 7.7: GE Healthcare